Pulmonary Hypertension Trial, Recruiting NCT07151768 Sponsor: Temple University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07151768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with a chronic lung disease (such as COPD, IPF, certain types of scarring or inflammation of the lungs, or advanced sarcoidosis affecting the lungs) confirmed through chest scans and/or breathing tests, and who also have a specific type of high blood pressure in the lungs (called pre-capillary pulmonary hypertension), confirmed through a procedure that measures pressures in the heart and lungs.
  • People who are willing and able to attend follow-up visits and be reachable by phone for the full length of the study.
  • People who are able to take part in required tests, including tests done while walking or moving around.

Who may not be able to join:

  • People who have high blood pressure in the lungs that is not related to a chronic lung disease — for example, certain other types of pulmonary hypertension such as idiopathic pulmonary arterial hypertension, heart-related pulmonary hypertension, or chronic blood clot-related pulmonary hypertension (confirm with trial site if unsure which type applies).
  • People who have a serious, uncontrolled illness affecting other parts of the body — such as uncontrolled heart disease or an active cancer — that could affect life expectancy.
  • People who have previously had a lung or heart transplant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 267-990-3630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Temple University
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prediction of one year mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov